GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Cyclically Adjusted Revenue per Share

China National Accord Medicines (SZSE:000028) Cyclically Adjusted Revenue per Share : ¥101.05 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

China National Accord Medicines's adjusted revenue per share for the three months ended in Mar. 2024 was ¥34.373. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥101.05 for the trailing ten years ended in Mar. 2024.

During the past 12 months, China National Accord Medicines's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of China National Accord Medicines was 25.30% per year. The lowest was 9.60% per year. And the median was 16.10% per year.

As of today (2024-05-27), China National Accord Medicines's current stock price is ¥38.65. China National Accord Medicines's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥101.05. China National Accord Medicines's Cyclically Adjusted PS Ratio of today is 0.38.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of China National Accord Medicines was 1.87. The lowest was 0.25. And the median was 0.60.


China National Accord Medicines Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for China National Accord Medicines's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Cyclically Adjusted Revenue per Share Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.70 75.11 83.57 92.42 98.95

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.22 95.62 97.80 98.95 101.05

Competitive Comparison of China National Accord Medicines's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, China National Accord Medicines's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Cyclically Adjusted PS Ratio falls into.



China National Accord Medicines Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China National Accord Medicines's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=34.373/115.2271*115.2271
=34.373

Current CPI (Mar. 2024) = 115.2271.

China National Accord Medicines Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 12.898 98.200 15.134
201409 13.334 98.900 15.535
201412 12.938 99.000 15.059
201503 13.275 99.900 15.312
201506 13.905 99.500 16.103
201509 14.565 100.500 16.699
201512 23.013 100.600 26.359
201603 18.765 102.200 21.157
201606 18.625 101.400 21.165
201609 19.172 102.400 21.574
201612 18.314 102.600 20.568
201703 18.464 103.200 20.616
201706 18.443 103.100 20.612
201709 19.326 104.100 21.392
201712 17.914 104.500 19.753
201803 18.327 105.300 20.055
201806 19.037 104.900 20.911
201809 19.734 106.600 21.331
201812 20.466 106.500 22.143
201903 21.707 107.700 23.224
201906 24.406 107.700 26.112
201909 24.678 109.800 25.898
201912 23.990 111.200 24.859
202003 22.997 112.300 23.596
202006 25.725 110.400 26.850
202009 28.324 111.700 29.218
202012 29.970 111.500 30.972
202103 28.913 112.662 29.571
202106 30.603 111.769 31.550
202109 30.732 112.215 31.557
202112 32.501 113.108 33.110
202203 30.844 114.335 31.085
202206 33.989 114.558 34.188
202209 33.170 115.339 33.138
202212 33.891 115.116 33.924
202303 33.535 115.116 33.567
202306 35.357 114.558 35.564
202309 32.889 115.339 32.857
202312 33.664 114.781 33.795
202403 34.373 115.227 34.373

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


China National Accord Medicines  (SZSE:000028) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

China National Accord Medicines's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=38.65/101.05
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of China National Accord Medicines was 1.87. The lowest was 0.25. And the median was 0.60.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


China National Accord Medicines Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines